- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SRY-box transcription factor 9 (SOX9) is a nuclear transcription factor that plays a central role in embryonic development, lineage specification, and maintenance of progenitor cell populations, where it regulates gene expression programs controlling differentiation and cellular plasticity. SOX9 Antibody is widely used to investigate transcriptional networks associated with stem-like states and has become an important marker in cancer research due to its involvement in tumor initiation, progression, and resistance mechanisms.
SOX9 Antibody / Cancer Stem Cell Marker Antibody is particularly valuable for studying cancer stem cell biology, where SOX9 expression is frequently enriched in tumor-initiating cell populations that exhibit self-renewal capacity and resistance to chemotherapy and radiation. SOX9 antibody, also known as SRY-box transcription factor 9 antibody, is commonly used to identify these subpopulations across a range of malignancies, including colorectal, pancreatic, lung, ovarian, and prostate cancers, where elevated SOX9 expression correlates with aggressive tumor behavior and poor clinical outcomes.
Mechanistically, SOX9 functions downstream of key developmental signaling pathways including Wnt/beta-catenin, Notch, and Hedgehog, integrating extracellular signals to promote stemness while suppressing terminal differentiation. In tumor contexts, aberrant activation of SOX9 contributes to epithelial-mesenchymal transition (EMT), enhanced migratory capacity, and increased invasive potential. SOX9 Antibody enables detection of nuclear SOX9 in experimental systems investigating these processes, supporting studies of tumor plasticity, metastatic progression, and transcriptional reprogramming.
In addition to its role in cancer stem cell maintenance, SOX9 is associated with glandular differentiation and tissue remodeling, particularly in organs such as pancreas, intestine, and lung. Tumor regions exhibiting active proliferation and structural reorganization often show increased SOX9 expression, reflecting its role in maintaining progenitor-like phenotypes within dynamic tumor microenvironments. SOX9 Antibody supports identification of these biologically relevant cell populations and facilitates analysis of tumor heterogeneity.
Beyond oncology, SOX9 is essential for normal developmental processes including chondrogenesis, gonadal development, and organogenesis, highlighting its role as a master regulator of lineage commitment. Its reactivation in cancer underscores the overlap between developmental signaling pathways and tumor biology. SOX9 Antibody provides a robust tool for examining these shared mechanisms in both normal and disease states.
Overall, SOX9 Antibody is well suited for investigating transcriptional regulation, cancer stem cell signaling, and cellular plasticity. Its strong association with stemness pathways and tumor progression makes it a valuable reagent for research focused on tumor initiation, therapeutic resistance, and identification of novel targets in oncology.
This SOX9 antibody is part of a broader SOX9 antibody panel offered by NSJ Bioreagents.
Optimal dilution of the SOX9 Antibody / Cancer Stem Cell Marker Antibody should be determined by the researcher.
A portion of amino acids 393-508 was used as the immunogen for the SOX9 antibody.
Aliquot the SOX9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
SOX9 antibody, SRY-box transcription factor 9 antibody, SOX9 stem cell marker antibody, SOX9 cancer marker antibody, SOX9 transcription factor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.